Breast cancer

Not Applicable

• Conditions: Health Condition 1: C508- Malignant neoplasm of overlappingsites of breast

• Registration Number: CTRI/2023/01/048930
• Lead Sponsor: Rohilkhand Medical College and Hospital, Bareilly

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 February 2023

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

All histopathologically diagnosed cases of Invasive breast carcinoma in which molecular classification has been done, in the Department of Pathology, Rohilkhand Medical College and Hospital, Bareilly

Exclusion Criteria

1 Patient who received radiotherapy and chemotherapy.

2 Cases other than Invasive breast carcinoma.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To study the immunohistochemical expression of p53 Biomarker in cases of Invasive Breast Carcinoma and its correlation with various prognostic markers.Timepoint: After operative procedure.

Secondary Outcome Measures

Name	Time	Method
ilTimepoint: Nil